Acutus Medical
Acutus Medical Q2 FY22: revenue $4.1M; diluted EPS $0.16
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001628280-22-022514
- Document
- 10-Q
Key figures from this report
These are the numbers Acutus Medical reported for Q2 FY22, the quarter ended Jun 30, 2022, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$4.1MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Net income$5.7MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Diluted EPS$0.16No year-earlier figure tagged10-Q income statement, on EDGAR
- Cash and cash equivalents$46.6MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
- Cash from operations−$20.6MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Adagio Medical Holdings ADGM
- Aethlon Medical AEMD public float $6M, Sep 30, 2025
- ALR Technologies SG ALRTF
- Allurion Technologies ALUR public float $21M, Jun 30, 2025
- Autonomix Medical AMIX public float $6M, Sep 30, 2025
